CLINICAL TRIALS

    Silo Pharma (SILO) Issues Letter to Shareholders

    Silo Pharma, Psychedelic Stock Review, Psyilo

    Silo Pharma (SILO) $3.36 Achieves New Milestone for SP-26 Therapeutic -Initiates...

    Silo Pharma (SILO) Attends Dawson James Conference.

    Icannex

    Australian Icannex (IHL:ASX) Headed to NASDAQ?

    Psychedelic Stock Review Initiates Coverage on Ehave Inc.

    Small Pharma (DMTTF) Successfully Completes Phase I Clinical Trial Of DMT...

    atai

    Huge News on Opioid Addiction From atai (ATAI).

    Ehave (EHVVF) Announces Update On Ehave Medical App With The Launch...

    Revive Therapeutics

    Revive Therapeutics (RVVTF) Provides Update on Psychedelics Clinical Product Pipeline

    PSYCHEDELIC STOCK REVIEW, EHAVE

    Adding Ehave (EHVVF) to Psychedelic Stock Watch List.

    ©